28 November 2018 - The proposal allows insurers to stop covering certain "protected" classes of drugs used to treat common ailments like depression, cancer and HIV infection.
The Trump administration is making good on its latest effort to lower out-of-pocket drug costs for Medicare recipients, but its approach could also limit drug options or even risk eliminating coverage of some prescriptions.
CMS proposed late Monday changes to Medicare Advantage and Medicare Part D.